US11192958B2

Monoclonal antibodies for use in diagnosis and therapy of cancers and …

University of Texas System

Abstract

The specification describes the sequences for antibodies that recognize the HLA-A2-restricted peptide PR-1 in the context of HLA presentation on the surface of cancer cells. Use of these antibodies in the diagnosis and treatment of cancer and immune-related diseases are also provided.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Jeffrey Molldrem
Priority date: July 10, 2012
Filing date: February 13, 2018
Grant date: December 07, 2021
Publication date: December 07, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/73/76/34/efe0622b2eb82a/US11192958.pdf
Metadata fetched: August 29, 2026 00:27